The clinical information you need, at your fingertips.

Modestly higher alopecia rates showed up in adults with type 2 diabetes on GLP-1 receptor agonists. . .

Meta-analysis suggests plasmapheresis may improve outcomes in steroid-refractory or severe MOGAD attacks, with few safety concerns. . .

National study highlights the need for earlier diagnosis and better cardiovascular risk management to improve long-term outcomes. . .

Zidesamtinib was designed to overcome resistance mutations and improve brain penetration, addressing key limitations of earlier ROS1-targeted treatments. . .

Investigational islatravir/lenacapavir regimen maintained viral suppression through 48 weeks, potentially offering the first once-weekly oral treatment option for people with HIV. . .